CARIS LIFE SCIENCES, INC. Increase (Decrease) in Accounts Payable
CARIS LIFE SCIENCES, INC. (CAI) reported Increase (Decrease) in Accounts Payable of $39.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $23.26M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $16.37M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $12.23M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $729.00K, a 70.01% decline year-over-year.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was $11.04M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was -$226.00K, a 103.15% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was $7.17M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $39.63M 10-Q · filed 2026-08-05 | $51.86M derived: sum of 3 quarters · filed 2026-08-05 | $52.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $16.37M 10-Q · filed 2026-05-08 | $28.60M derived: sum of 2 quarters · filed 2026-05-08 | $29.33M derived: sum of 3 quarters · filed 2026-05-08 | $29.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $12.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $12.96M derived: sum of 2 quarters · filed 2026-03-03 | $12.77M derived: sum of 3 quarters · filed 2026-08-05 | $11.04M 10-K · filed 2026-03-03 |
| 2025-09-30 | $729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $543.00K derived: sum of 2 quarters · filed 2026-08-05 | -$1.20M 10-Q · filed 2025-11-05 | -$6.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.93M 10-Q · filed 2026-08-05 | -$7.21M derived: sum of 3 quarters · filed 2026-08-05 | -$4.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.74M 10-Q · filed 2026-05-08 | -$7.02M derived: sum of 2 quarters · filed 2026-05-08 | -$4.59M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.85M derived: sum of 2 quarters · filed 2026-03-03 | -$226.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.05M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $2.62M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $7.17M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |